Key Takeaways
- EBITDA turned positive at Rs. 46 crores as PVC prices bottomed and feedstock costs eased, but a fresh import-driven price correction in October will weigh on Q3.
- Custom Manufacturing is scaling fast: three new LOIs signed, including the company's first active ingredient, and the business remains on track for 20–25% growth this year toward a Rs. 1,000 crores revenue target.
- Paste PVC is the swing factor for standalone profitability: caustic soda makes money, but Paste PVC contribution needs roughly another $200/mt to bring the specialty business back into the black.
- China's slowdown is the external risk that matters most: its construction weakness is spilling excess PVC into India, and the domestic industry's push for trade measures is not yet effective.
- What to watch next quarter: whether the October PVC price correction proves temporary, progress on antidumping/quantitative restrictions, and the pace of Custom Manufacturing commercialization from the new LOIs.
PVC: The Recovery, the Correction, and China
- Q2 recovery was real but brief: Suspension and Paste PVC prices rose through July and August after bottoming in late June, lifting gross margins from 27% to 34% and pulling EBITDA back into positive territory.
- Imports reversed the gains: heavy Chinese arrivals toward the end of Q2 spilled into Q3 and triggered a price correction in early October, which management says will impact Q3 margins. Prices started moving up again only from end-October.
- China is the structural overhang: China, the world's largest PVC producer and consumer, is in a construction-led slowdown (the sector is ~25% of GDP), and that weakness is being exported regionally. Chinese government stimulus announced in September is expected to translate into actual demand only "in a couple of quarters."
- Domestic demand is not the problem: infrastructure and real estate activity in India keep underlying PVC demand strong; the pressure is entirely on the supply side from imports.
- Trade defence is stuck in process: the industry has filed for antidumping and quantitative restrictions, and the DGTR has notified quantitative measures, but the final gazette notification, the step that makes them effective, is still pending. Management is "confident something will come through soon."
- Stability matters more than price level: because feedstock costs track PVC prices closely, margins can be preserved even at lower absolute prices if volatility subsides.
Ramkumar Shankar: "Stability is all that we want. It doesn't necessarily need to be at high levels. It can be even able at lower levels of prices because since the feedstock also follows the PVC prices very closely, the margins would still be there even at the lower levels."
Custom Manufacturing: LOIs, the First AI, and the Growth Path
- Three LOIs signed, each different: the first is an intermediate for a newly launched molecule, the second is an intermediate for an established generic active ingredient, and the third, the most significant, is an active ingredient itself for a new pipeline molecule still in pre-launch.
- The third LOI is a milestone on multiple fronts: it is the company's first active ingredient (all nine existing products are intermediates), involves complex multi-step chemistry, and validates the stated strategy of staying in custom manufacturing only, never competing with customers. The customer provided the technology package; Chemplast will optimize it further.
- The AI has a long runway: because the molecule is patented, not generic, Chemplast expects participation "well beyond 5 years," with supply agreements typically structured as 3–5 year contracts carrying volume commitments and a price formula.
- Phase 1 of the new multipurpose block is commissioned and ramping: three additional molecules are being commercialized now, taking the product count from eight to eleven. Phase 2 completion is expected by end of FY24.
- Growth is on track: management reaffirmed 20–25% Custom Manufacturing growth this year and the Rs. 1,000 crores revenue target in 3–4 years. The current nine molecules plus the three LOIs would likely fully utilize the new block, requiring planning for additional capacity.
- Customer concentration will persist near-term: dependency on 1–2 customers remains, but the new production block enables discussions with new customers, and diversification is expected to improve significantly over the medium to long term.
- Agrochem destocking is reversing: demand appears to be recovering after the destocking that hurt the previous quarter, and additional molecules being commercialized have compensated for the softness.
Krishnakumar Rangachari: "This is a validation of our stated intent of being only in the custom manufacturing space and not compete with our customers. And so because of this, they trust us in the manufacture of the final product itself."
Paste PVC and the Standalone Profitability Puzzle
- Caustic soda is profitable standalone: the loss in the standalone business is not a caustic problem; it is driven by Paste PVC price volatility and the timing of Custom Manufacturing sales, which are weighted to the second half.
- Paste PVC needs roughly another $200/mt: management said that level of contribution increase "would certainly help" the specialty business return to profitability, and at FY23 contribution levels of ~$400/mt, "definitely Chemplast will deliver." No precise breakeven was given.
- Paste PVC prices are sentiment-driven: they are influenced by the mood around Suspension PVC, so the recent slide in Suspension PVC prices pulled Paste PVC down with it.
- Capacity expansion is imminent: the 41,000-ton Paste PVC expansion will be commissioned in Q3 of FY24, adding volume leverage when prices recover.
Other Chemicals and Caustic Soda
- Other Chemicals segment was flat sequentially despite an 8% volume increase, because prices of caustic soda and chloromethanes corrected further in Q2 versus Q1.
- Chloromethanes are under divergent pressure: chloroform and carbon tetrachloride face pricing pressure (the latter from agrochemical weakness in Latin America), while methylene dichloride remains strong. Recovery in the pressured products is expected in "a couple of quarters."
- Caustic soda saw a false dawn: prices recovered briefly in September but corrected again in October. India has overcapacity, and balancing happens via exports from Western coast producers, which causes price corrections.
- Medium-term caustic demand story is intact: significant demand growth is expected from the EV sector (nickel mining, battery manufacturing additives) plus traditional drivers like alumina, paper, and textiles.
Costs, Margins, and the Historical Context
- Cost reduction helped the Q2 recovery: other expenses declined 8% sequentially, mainly from a 10% reduction in energy costs.
- Gross margins rebounded sharply: from 27% in Q1 to 34% in Q2, driven by higher PVC prices and lower feedstock costs.
- Historical profitability provides a benchmark: excluding the unusual last two quarters, Chemplast has consistently delivered ~25% EBITDA margin for the past seven years, a level management clearly views as normalised.
N Muralidharan: "If you leave out FY22-23 and the current year, till then, at least for the past 7 years, they have been consistently doing EBITDA margin of around 25%."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Custom Manufacturing growth | 20–25% revenue growth this year | FY24 |
| Custom Manufacturing revenue target | Rs. 1,000 crores | 3–4 years |
| LOI deliveries commence | First deliveries from the two recently signed LOIs | H2 FY24 |
| Phase 2 multipurpose block | Completion | End of FY24 |
| Paste PVC capacity expansion | 41,000 tons commissioned | Q3 FY24 |
| PVC business recovery | Gradual recovery | Next 2–3 quarters |
| Other Chemicals recovery | Normalcy restored | Next 2–3 quarters |
| Chinese stimulus impact on PVC demand | Translation into actual demand | "A couple of quarters" |
| Chloroform and carbon tetrachloride recovery | Pricing pressure to ease | "A couple of quarters" |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Revenue from operations | ₹988 cr, flat QoQ |
| Gross margin | 34%, recovered from 27% in Q1 FY24 |
| EBITDA | ₹46 cr, versus EBITDA loss of ₹35 cr in Q1 FY24 |
| Finance cost | ₹39 cr |
| PAT | ₹26 cr |
| H1 FY24 revenue | ₹1,984 cr |
| H1 FY24 EBITDA | ₹11 cr |
| H1 FY24 PAT | Loss of ₹38 cr |
| Consolidated net debt | ₹321 cr as of 30 Sep 2023 |
| Suspension PVC-VCM spread | $199/mt in Q2 |
| Paste PVC contribution | Close to $200/mt in Q2 |
| Suspension PVC production | 81,800 tons in Q2, versus 77,600 tons in Q2 FY23 |
| Suspension PVC production H1 | 165,000 tons, versus 159,000 tons in H1 FY23 |
| Paste PVC price increase | 4.5% sequential increase in Q2 |
| Speciality Chemicals volume growth | 4% sequential uptick in Q2 |
| Custom Manufactured Chemicals revenue growth guidance | 20% to 25% growth expected this year |
| Custom Manufactured Chemicals FY23 turnover | ~₹325 cr |
| Custom Manufactured Chemicals revenue target | ₹1,000 cr in next 3 to 4 years |
| Custom Manufacturing site workforce | ~400 chemists and engineers |
| Custom Manufacturing total gross block | ₹765 cr (₹680 cr new + ₹85 cr earlier) |
| Paste PVC capacity expansion | 41,000 tons, commissioning in Q3 FY24 |
| Suspension PVC inventory | Less than 1 day of production |
| China Suspension PVC imports into India | 269,000 tons in Jul-Sep quarter, up from 164,000 tons in Apr-Jun |
| Other Expenses decline | 8% sequential decline, driven by 10% reduction in energy costs |
| Paste PVC contribution in FY23 | $400/mt |
| Current CFR Asia Suspension PVC price | $770/mt pre-duty |
| Current CFR Asia VCM price | $615/mt |
| Chinese PVC futures price | 6,200 RMB, recovered from 5,900 RMB |
| Capex for Paste PVC project | ~₹360 cr, asset turn ~1.2x at current prices |
| Custom Manufacturing capex asset turn | ~1.3x |
| Historical EBITDA margin (past 7 years, excl. FY22-23 and current year) | ~25% |